Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Jul 7, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-06$1.75/sh−6,634$11,625→ 278,367 total
Footnotes (2)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $1.7523, and the range of prices were between $1.65 and $1.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.